A coalition of 34 scientific and medical organizations led by the American Association of Immunologists and the American College of Physicians released the following statement.
AMCP Letter on 21st Century Cures 2.0
On Aug. 2, AMCP submitted comments in response to the 21st Century Cures 2.0 Request for Information. AMCP’s comments detail the association’s support for many of the provisions included in the Cures 2.0 Act of 2021. The bill, introduced in the previous Congress by Congresswoman Diana DeGette (D-CO), would increase coverage of innovative technologies, improve Medicaid access to high-cost therapies, and improve post-marketing studies of drugs approved through accelerated pathways.
Related
The Protecting Pharmacies in Medicaid Act would prohibit the use of spread pricing arrangements in Medicaid programs. Pharmacy benefit managers (PBMs) would be required to pass through to pharmacies the full amount of the money paid to the PBMs by Medicaid programs, except for a fixed administrative fee. The total reimbursement amount will be determined by a survey of national average drug acquisition costs administered by the Department of Health & Human Services.
In AMCP's latest comments to the FDA, we emphasize the need for standardized public reporting of confirmatory trial progress, ensuring payers and health care providers have the necessary data to make informed coverage decisions. By supporting proactive communication and rigorous confirmatory trials, AMCP aims to balance early access to innovative treatments with patient safety and long-term therapeutic value.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
